secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0001601485-25-000096
Event type: debt
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio Therapeutics secures $10M senior secured note from board-affiliated investor
--------------------------------------------------------------------------------

- Issued $10M promissory note to GKCC (controlled by board member); interest rate up to 12.5%.
- Warrant to purchase 103,225 shares at $7.75 issued; immediately exercisable, 5-year term.
- Proceeds plus current cash expected to fund operations into Q1 2026.
- AMPLIFY-7P Phase 2 interim analysis for ELI-002 in PDAC anticipated in Q3 2025.
- Note matures June 3, 2028; 24-month interest-only period with lump-sum interest payment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148525000096/0001601485-25-000096-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148525000096/angn-20250604.htm
  HTML page:      https://secwatch.observer/filing/0001601485-25-000096

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer